Sagility Ltd

Sagility Share Pledge

Sagility B.V. disclosed release of indirect encumbrance on 56 crore shares after an on-market bulk deal sale. Promoter holding reduced from 50.95% to 38.99%.

Sagility Promoter Selling

Sagility B.V., a promoter, sold 560 million shares in the open market on November 2, 2026. Its stake fell from 50.95% to 38.99%.

Sagility Dividend

Sagility Limited declared an interim dividend of ₹0.15 per equity share for the financial year 2026-27. The record date is set for October 30, 2026.

Sagility Results Update

Sagility Ltd reported Q2 FY27 revenue of ₹2,032.1 Crore, up 22.5% YoY. The company also declared an interim dividend of ₹0.15 per share.

Sagility Investor Presentation: Key Takeaways

Sagility reported strong Q2 FY27 performance with 22.5% YoY revenue growth and 26.3% adjusted EBITDA margin. Performance driven by organic expansion in payer segments and strategic acquisition of Chirok Health.

Sagility Q2 FY27 Results: Net Profit ₹284.2 Cr, Up 13.3% YoY

Sagility Ltd reported revenue from operations of ₹2,032 Cr (+22.5% YoY) and net profit of ₹284.2 Cr (+13.3% YoY) for Q2 FY27.

Key figure

Net profit ₹284.2 Cr · +13.3% YoY

Sagility Acquisition Worth ₹304.1 Cr

Sagility's US subsidiary is acquiring Chirok Health LLC for up to US$ 32.35 million. This 100% stake acquisition strengthens Sagility's provider segment capabilities.

Value

₹304.1 Cr

Sagility Board Meeting Date

Sagility Ltd disclosed its Board is scheduled for 22 Oct 2026 to consider Q1/H1 FY27 results and any interim dividend. No decision has been taken yet.

Sagility Other Announcement

Sagility Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, disclosing promoter holdings and ongoing indirect encumbrances.

Sagility Management Change

Sagility Ltd announced the resignation of Daniel B. Bailey as Global General Counsel and the appointment of Brian Clayton to the same role, effective October 2, 2026.

Sagility Other Announcement

Sagility Limited informs shareholders that dividend payments have been processed. Shareholders with rejected payments must update KYC details with their DPs to receive withheld funds.